Healthpeak Properties (NYSE:DOC) Cut to Sell at StockNews.com

Healthpeak Properties (NYSE:DOC) was downgraded by research analysts at StockNews.com from a “hold” rating to a “sell” rating in a report released on Thursday.

A number of other analysts have also weighed in on DOC. Argus raised shares of Healthpeak Properties to a “strong-buy” rating in a research note on Thursday, May 9th. JPMorgan Chase & Co. upped their target price on Healthpeak Properties from $19.00 to $21.00 and gave the stock a “neutral” rating in a research report on Thursday, May 16th. Scotiabank lifted their price target on Healthpeak Properties from $22.00 to $23.00 and gave the company a “sector outperform” rating in a research report on Thursday, May 16th. Evercore ISI raised Healthpeak Properties to a “strong-buy” rating in a research note on Monday. Finally, Wedbush boosted their price target on shares of Healthpeak Properties from $22.00 to $25.00 and gave the stock an “outperform” rating in a research report on Monday. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, seven have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Healthpeak Properties has an average rating of “Moderate Buy” and a consensus price target of $20.64.

Healthpeak Properties Stock Performance

DOC stock traded down $0.10 on Thursday, reaching $21.72. The company’s stock had a trading volume of 4,469,632 shares, compared to its average volume of 6,060,838. Healthpeak Properties has a 52 week low of $15.24 and a 52 week high of $22.19. The company has a debt-to-equity ratio of 0.91, a current ratio of 0.70 and a quick ratio of 0.69. The company has a market capitalization of $15.29 billion, a P/E ratio of 62.06, a price-to-earnings-growth ratio of 2.73 and a beta of 1.11. The firm has a fifty day moving average of $19.99 and a two-hundred day moving average of $17.44.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings results on Thursday, July 25th. The real estate investment trust reported $0.21 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.44 by ($0.23). Healthpeak Properties had a return on equity of 3.51% and a net margin of 11.93%. The business had revenue of $695.50 million during the quarter, compared to the consensus estimate of $665.11 million. During the same period in the previous year, the company posted $0.45 EPS. The company’s revenue for the quarter was up 27.5% compared to the same quarter last year. As a group, analysts predict that Healthpeak Properties will post 1.79 EPS for the current fiscal year.

Hedge Funds Weigh In On Healthpeak Properties

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Parallel Advisors LLC grew its stake in Healthpeak Properties by 274.6% during the 4th quarter. Parallel Advisors LLC now owns 4,072 shares of the real estate investment trust’s stock valued at $54,000 after acquiring an additional 2,985 shares in the last quarter. Quadrant Capital Group LLC increased its stake in Healthpeak Properties by 645.4% in the 4th quarter. Quadrant Capital Group LLC now owns 9,646 shares of the real estate investment trust’s stock valued at $128,000 after buying an additional 8,352 shares during the period. Stratos Wealth Partners LTD. purchased a new stake in Healthpeak Properties in the 4th quarter worth approximately $134,000. Koshinski Asset Management Inc. purchased a new stake in Healthpeak Properties in the 4th quarter worth approximately $146,000. Finally, Sapient Capital LLC acquired a new stake in shares of Healthpeak Properties during the 4th quarter valued at $152,000. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.